Morning Briefing
Summaries of health policy coverage from major news organizations
Senate Panel Votes To End Drug Industry's Practice Of 'Pay-To-Delay' Generics
A Senate panel Friday voted in favor of legislation that would disallow brand name drug companies from paying generic brands to keep off the market.
This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
